About: Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 1981

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 1981 (uk) artículu científicu espublizáu n'avientu de 1981 (ast) im Dezember 1981 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 December 1981 (en)
publication date	wds:Q70201661-38107443-108F-404E-BBC0-1C3352DB988B
publication date	1981-12-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q70201661-0AB5472E-AC32-4B6C-8034-E6F899FEEBCB wds:Q70201661-60805C15-2995-4B09-A72F-A0CC214620CF wds:Q70201661-8EF21EAB-B9B5-4ED9-B3D1-81B92E7F32E0 wds:Q70201661-BA70FD1A-8857-4908-9125-158B1BE51711
author name string	M Boscaro F Mantero D Armanini F Fallo
rdfs:label	Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism (en) Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism (nl)
skos:prefLabel	Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism (en) Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism (nl)
name	Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism (en) Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism (nl)
author	wds:Q70201661-1C70438A-AB75-4C8D-B586-3C7EB6EA5BBA wds:Q70201661-FB4B4312-FC89-4026-AC7E-53C1BF722F67
author	Giuseppe Opocher Carla Scaroni
title	wds:Q70201661-C77939A9-E0C6-4563-A452-CBA82C4B6A1F
title	Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism (en)
page(s)	wds:Q70201661-5BDBEAA6-A891-4158-AF40-D2C57955057A
page(s)	289s-293s
instance of	wds:Q70201661-BAFB77BD-16B5-4007-B28A-AF4682EF6B33
instance of	scholarly article
PubMed ID	wds:Q70201661-5FA19BEC-53B3-46A3-A97F-2C592B0779C4
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7032817
PubMed ID	7032817
published in	wds:Q70201661-FB33A4A1-76FE-4579-BD60-04A7B725F37C
published in	Clinical Science
volume	wds:Q70201661-A0989386-641F-479A-852C-3E7985A93479
volume	61 Suppl 7
DOI	wds:Q70201661-9CDC392D-8E4D-41E9-89A4-723C3F296995
DOI	http://dx.doi.org/10.1042/CS061289S
DOI	10.1042/CS061289S
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70201661
is cites work of	Primary aldosteronism: from bench to bedside Primary aldosteronism - treatment options Angiotensin-converting enzyme inhibitors: past, present, and bright future The relation of adiponectin and tumor necrosis factor alpha levels between endothelial nitric oxide synthase, angiotensin-converting enzyme, transforming growth factor beta, and tumor necrosis factor alpha gene polymorphism in adrenal incidentalomas Cellular origin of aldosteronomas The renin-angiotensin systems. Dexamethasone-suppressible hyperaldosteronism: pathophysiology, clinical aspects, and new insights into the pathogenesis Captopril before and after spironolactone therapy in primary aldosteronism. Pathogenetic and therapeutical aspects [Modern pharmacological aspects of hyperaldosteronism therapy]. Treatment of primary aldosteronism: Where are we now?
is cites work of	wds:Q37951385-1C04B3C2-7821-4E21-9BB0-3A18ED39A0DF wds:Q36186530-A642F218-5B84-4081-A7E1-93F3167F7D33 wds:Q39343506-AEAE95A3-F9FC-4F71-93AE-F230F8726D46 wds:Q35197872-CB354014-9F89-4FB5-9B11-D6E680DB7D9C wds:Q69893529-184B260C-9122-49A0-A800-0F526A89B6D7 wds:Q39666935-FB6580CA-A32F-4E70-885D-BBEAF81D6900 wds:Q52931938-D02EB9AC-5F77-4A68-9A2B-D47FA10D62EC wds:Q37838328-E9609727-34C5-4A84-8804-84B6265A91AC wds:Q42454889-92EB8684-C2C5-4B62-AF8B-AD1EC466388C wds:Q41371935-13032F2E-B482-4204-B1C0-34AB31B19D6E

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 182 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software